These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 35902169)

  • 21. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Changes and Clinical Implications of Delayed Peridevice Leak Following Left Atrial Appendage Closure.
    Afzal MR; Gabriels JK; Jackson GG; Chen L; Buck B; Campbell S; Sabin DF; Goldner B; Ismail H; Liu CF; Patel A; Beldner S; Daoud EG; Hummel JD; Ellis CR
    JACC Clin Electrophysiol; 2022 Jan; 8(1):15-25. PubMed ID: 34454881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
    Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
    Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
    Doshi SK; Kar S; Sadhu A; Horton R; Osorio J; Ellis C; Stone J; Shah M; Dukkipati SR; Adler S; Nair DG; Kim J; Wazni O; Price MJ; Holmes DR; Shipley R; Christen T; Allocco DJ; Reddy VY;
    J Am Heart Assoc; 2023 Feb; 12(4):e026295. PubMed ID: 36789852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
    Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.
    Reddy VY; Sievert H; Halperin J; Doshi SK; Buchbinder M; Neuzil P; Huber K; Whisenant B; Kar S; Swarup V; Gordon N; Holmes D;
    JAMA; 2014 Nov; 312(19):1988-98. PubMed ID: 25399274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience.
    Bai R; Horton RP; DI Biase L; Mohanty P; Pump A; Cardinal D; Scallon C; Mohanty S; Santangeli P; Brantes MC; Sanchez J; Burkhardt JD; Zagrodzky JD; Gallinghouse GJ; Natale A
    J Cardiovasc Electrophysiol; 2012 May; 23(5):455-61. PubMed ID: 22082312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the LAmbre device-Data from a prospective multicenter clinical study.
    Wang G; Kong B; Qin T; Liu Y; Huang C; Huang H
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):354-359. PubMed ID: 33251673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure.
    Musikantow DR; Shivamurthy P; Croft LB; Kawamura I; Turagam MK; Whang W; Dukkipati SR; Goldman ME; Reddy VY
    Heart Rhythm; 2021 May; 18(5):717-722. PubMed ID: 33549807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Waksman R; Pendyala LK
    Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peridevice Leak After Left Atrial Appendage Closure: Incidence, Risk Factors, and Clinical Impact.
    Nguyen A; Gallet R; Riant E; Deux JF; Boukantar M; Mouillet G; Dubois-Randé JL; Lellouche N; Teiger E; Lim P; Ternacle J
    Can J Cardiol; 2019 Apr; 35(4):405-412. PubMed ID: 30935631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors, clinical implications, and management of peridevice leak following left atrial appendage closure: A systematic review.
    Helal B; Khan J; AlJayar D; Khan MS; Alabdaljabar MS; Asad ZUA; DeSimone CV; Deshmukh A
    J Interv Card Electrophysiol; 2024 Jun; 67(4):865-885. PubMed ID: 38182966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.